You are viewing the site in preview mode

Skip to main content

Table 4 Clinical characteristics at baseline (initial evaluation) and at re-evaluation 3 years later

From: Deterioration in saliva quality in patients with Sjögren’s syndrome: impact of decrease in salivary epidermal growth factor on the severity of intraoral manifestations

  Baseline (initial evaluation) 3 years later (re-evaluation) p value
(a) SS group (n = 23)
 OHIP-14 score (out of 56) 10.2 ± 8.8 (n = 22) 12.6 ± 9.2 (n = 22) 0.040
 Salivary flow rate (mL/10 min) 8.1 ± 5.3 7.4 ± 5.1 0.149
 Salivary EGF output (pg/10 min) 10,158.4 ± 9820.9 8352.8 ± 7813.3 0.032
(b) Non-SS group (n = 14)
 OHIP-14 score (out of 56) 9.1 ± 6.8 10.7 ± 9.4 0.169
 Salivary flow rate (mL/10 min) 16.8 ± 6.7 16.7 ± 6.0 0.628
 Salivary EGF output (pg/10 min) 13,623.1 ± 9546.2 11,904.9 ± 6995.4 0.184
  1. Mean ± SD
  2. SS Sjögren’s syndrome, OHIP-14 Oral Health Impact Profile-14
Back to article page

Inflammation and Regeneration

ISSN: 1880-8190

Contact us